Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2016-07-07 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ROMILLE (35850), Ille-et-Vilaine
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BILLON HELEUX : revenue, balance sheet and financial ratios
PHARMACIE BILLON HELEUX is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ROMILLE (35850),
this company of category PME
shows in 2024 a net income positive of 205 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BILLON HELEUX (SIREN 821438066)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
204 637 €
243 616 €
250 947 €
183 621 €
146 814 €
181 823 €
119 233 €
71 168 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE BILLON HELEUX generates positive net income of 205 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2024: 71 k€ -> 205 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
204 637 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 51%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 59%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
51.279%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
59.211%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
716.978
490.619
307.081
209.62
156.772
110.283
64.794
51.279
Financial autonomy
11.365
15.98
22.609
30.057
35.619
42.259
53.402
59.211
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
51.282024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Good-12 pts over 3 years
In 2024, the debt ratio of PHARMACIE BILLON HELEUX (51.28) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
59.21%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Good+18 pts over 3 years
In 2024, the financial autonomy of PHARMACIE BILLON HELEUX (59.2%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 154.95. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
177.701
275.14
241.466
221.755
218.313
209.475
142.511
154.95
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
154.952024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Average-16 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE BILLON HELEUX (154.95) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE BILLON HELEUX in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE BILLON HELEUX is estimated at
2 856 883 €
(range 1 989 488€ - 4 274 061€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
1989k€2856k€4274k€
2 856 883 €Range: 1 989 488€ - 4 274 061€
NAF 5 année 2024
Valuation method used
Net Income Multiple
204 637 €
×
14.0x
=2 856 884 €
Range: 1 989 489€ - 4 274 062€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE BILLON HELEUX with other companies in the same sector:
Frequently asked questions about PHARMACIE BILLON HELEUX
What is the revenue of PHARMACIE BILLON HELEUX ?
The revenue of PHARMACIE BILLON HELEUX is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE BILLON HELEUX profitable?
Yes, PHARMACIE BILLON HELEUX generated a net profit of 205 k€ in 2024.
Where is the headquarters of PHARMACIE BILLON HELEUX ?
The headquarters of PHARMACIE BILLON HELEUX is located in ROMILLE (35850), in the department Ille-et-Vilaine.
Where to find the tax return of PHARMACIE BILLON HELEUX ?
The tax return of PHARMACIE BILLON HELEUX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BILLON HELEUX operate?
PHARMACIE BILLON HELEUX operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart